Below are the most recent publications written about "Follow-Up Studies" by people in Profiles.
-
Ruiz K, Serrano-Arroyo L, Valent?n-Rosa V, Torres-Borges G, Vil? LM. Long-term outcomes of hydroxychloroquine dose reduction in Puerto Ricans with systemic lupus erythematosus: 6-year follow-up. Lupus Sci Med. 2026 Mar 24; 13(1).
-
Rubinstein M, Lim S, McLean J, Rix J, Fuller L, Shingles H, Warner V, Hartshorne T, Cheshire C, Leet A, Taylor AJ, McGiffin DC, Bergin P, Merry C, Doi A, Gutman SJ, Hare JL, Marasco S, Kaye DM, Patel HC. Destination Ventricular Assist Device: A Single-Centre Experience With a Newly Approved Therapy for Advanced Heart Failure. Heart Lung Circ. 2026 Apr; 35(4):468-474.
-
Andr?s A, Jim?nez S, Aladr?n Regidor MJ, Moreso F, Crespo M, Serra Caba?as N, G?mez G, L?pez V, Carmen D?az Corte MD, Fraile-G?mez P, Lorenzo I, Ruiz San Mill?n JC, Ca?as L, Rodr?guez Benot A, Calvo Romero N, Diekmann F, Mendiluce A, Fern?ndez Rivera C, Gallego R, Jim?nez C, Martin-Moreno PL, Fern?ndez Tagarro E, D?az C, Mart?n Urcuyo B, Gonz?lez Roncero FM. Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study. Clin Transplant. 2026 Mar; 40(3):e70501.
-
Gao YP, Fan YT, Cheng XQ, Huang PN, Liu HY, Bi XJ, Sun J, Zhu Y, Zhou W, Liu YN, Deng YB. Incremental Value of NT-proBNP Over HCM-AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Clin Cardiol. 2026 Mar; 49(3):e70276.
-
Miyatani Y, Ogawa A, Sempokuya T, Tran C, James D, Seto T, Shikuma C, Kuwada SK. Ethnic disparities in metabolic dysfunction-associated steatotic liver disease and clinical outcomes. Front Endocrinol (Lausanne). 2025; 16:1739137.
-
Sun D, Tseng VL, Yu F, Coleman AL. Cardiovascular Risk and Eye Health: A Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence. Ophthalmology. 2026 May; 133(5):645-653.
-
Kuang H, Wang BN, Jia XY, Cui Z, Yu XJ, Jiang N, Borza DB, Zhao MH. Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease. Nephrol Dial Transplant. 2025 Dec 23; 41(1):55-66.
-
Cruz-Correa M, Oh DY, Kato K, Tabernero J, Bai Y, Shi J, Lee KW, Hirano H, Spigel D, Wyrwicz L, Pazo Cid R, Cubillo Graci?n A, Xu Y, Sheng T, Yang S, Xu RH, Moehler M. Tislelizumab?+?Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up. Adv Ther. 2026 Jan; 43(1):165-183.
-
Farrokhpour H, Ashrafi E, Mehravaran S, Sadeghi R, Mohammadi SF. Determinants of reoperation following cataract surgery: a real-world analysis from a large tertiary training eye hospital in Iran. Int Ophthalmol. 2025 Oct 29; 45(1):450.
-
Mo T, Joffe M, Cubasch H, Galukande M, Parham G, Pinder L, Zietsman A, Anderson BO, Naamala A, Kaggwa A, Nakazibwe T, Nteziryayo A, Pontac J, Offiah SA, Angelica A, Oyamienlen CS, Ezeigbo E, Iwuoha K, Chen WC, Walubita E, Lusaka M, Nyangasi M, Mohammed S, Narh CT, Boucheron P, Foerster M, Sch?z J, Dos-Santos-Silva I, McCormack V. Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 2025 Oct; 13(10):e1681-e1690.